On this page
- TL;DR
- Kidney cancer VA rating criteria (DC 7528)
- Kidney cancer residuals after treatment
- Is kidney cancer presumptive under the PACT Act?
- Is kidney cancer presumptive for radiation exposure?
- Camp Lejeune kidney cancer: the contaminated-water presumption
- How to prove kidney cancer is service connected without a presumption
- Why VA denies kidney cancer claims
- Questions veterans ask about kidney cancer
- Bottom Line
- Related Conditions and Tools
- Sources and limits
Kidney cancer is rated under 38 CFR § 4.115b, Diagnostic Code 7528, malignant neoplasms of the genitourinary system. Active malignancy is 100 percent. That part is uncontroversial.
The service-connection side is where the published guidance goes wrong. Kidney cancer has three presumptive routes, not one. The PACT Act route is statutory and lives in 38 U.S.C. § 1120, not in the fine-particulate-matter regulation most guides cite. Kidney cancer sits on the radiation-exposed veteran list too, reaching it indirectly in a way that is easy to miss reading the list itself. And kidney cancer is named on the Camp Lejeune contaminated-water list. I have not found a single result covering all three routes correctly.
TL;DR
- DC 7528 assigns 100 percent for a malignant genitourinary neoplasm, including renal cell carcinoma.
- The 100 percent continues past the end of treatment, with a mandatory VA examination at the expiration of six months.
- Any change from that examination is subject to 38 CFR § 3.105(e).
- With no local recurrence or metastasis, VA rates residuals as voiding dysfunction or renal dysfunction, whichever is predominant.
- Renal dysfunction is scored on glomerular filtration rate (GFR) bands, each requiring three consecutive months during the past twelve.
- When a whole kidney has been removed, DC 7500 sets a minimum evaluation of 30 percent.
- The PACT Act presumption is 38 U.S.C. § 1120(b)(2)(G), with covered-veteran eligibility from § 1119(c).
- Kidney cancer is not listed in 38 CFR § 3.320, § 3.320a, or § 3.320b. Citing those sections for kidney cancer is an error.
- Kidney cancer also qualifies under 38 CFR § 3.309(d) as cancer of the urinary tract, which the section defines to include the kidneys.
- Kidney cancer is on the Camp Lejeune list at § 3.309(f) for veterans with at least 30 days of service there between August 1, 1953 and December 31, 1987.
- Across 1,036 decided Board rulings on kidney cancer from 2021 to 2026, 30.0% were granted, 20.8% denied and 49.2% remanded. The grant rate is 5.3 points above the Board-wide 24.7 percent, and remand is the most common outcome.
Kidney cancer VA rating criteria (DC 7528)
DC 7528 covers malignant neoplasms of the genitourinary system as a group, so prostate, bladder, kidney, and testicular cancer all share the code. Its note controls the timing.
Following the cessation of surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure, the rating of 100 percent shall continue with a mandatory VA examination at the expiration of six months. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. If there has been no local reoccurrence or metastasis, rate on residuals as voiding dysfunction or renal dysfunction, whichever is predominant.
The 100 percent runs through treatment and for six months after treatment stops. The examination that ends it is mandatory. And the reduction that follows is a proposed reduction under § 3.105(e), which means VA must give you notice and an opportunity to respond before it takes effect.
Kidney cancer residuals after treatment
The residual choice is the reason two Board decisions on the same diagnosis can produce a 0 percent and a 30 percent. VA picks one framework, the one producing the predominant disability, and rates under it. It does not add them together.
Renal dysfunction: the GFR bands
Renal dysfunction is scored on GFR in 38 CFR § 4.115a.
- 100 percent. Chronic kidney disease with GFR less than 15 mL/min/1.73 m2 for at least three consecutive months during the past twelve; or requiring regular routine dialysis; or an eligible kidney transplant recipient.
- 80 percent. GFR from 15 to 29 for at least three consecutive months during the past twelve.
- 60 percent. GFR from 30 to 44 on the same three-month basis.
- 30 percent. GFR from 45 to 59 on the same three-month basis.
- 0 percent. GFR from 60 to 89 combined with recurrent casts, structural kidney abnormalities, or an albumin/creatinine ratio of 30 mg/g or higher, each on the same three-month basis.
Two features of these criteria matter in practice. The bands require persistence, not a single reading, so one bad lab draw does not establish a rating and one good one does not defeat it. And estimated GFR calculated by a medical professional is accepted for evaluation purposes under the note to this section. For how these bands work for kidney disease in general, see the kidney disease guide.
Voiding dysfunction
Voiding dysfunction is rated as urine leakage, urinary frequency, or obstructed voiding, whichever fits the condition. Continual leakage requiring absorbent materials changed more than four times per day is 60 percent, two to four times per day is 40 percent, and less than twice per day is 20 percent. Urinary frequency runs 40, 20, and 10 percent by daytime voiding interval and nighttime awakenings. Obstructed voiding reaches 30 percent for urinary retention requiring catheterization.
Removal of a kidney: the 30 percent minimum (DC 7500)
The schedule has a separate code for the loss of a kidney. DC 7500, removal of one kidney, carries a minimum evaluation of 30 percent, or a rating as renal dysfunction if there is nephritis, infection, or other disease in the remaining kidney. Under 38 CFR § 4.115, when absence of a kidney is the only kidney disability, the absent kidney and any hypertension or heart disease are rated separately. The Board has applied this to kidney cancer: in a December 2023 decision, a veteran's renal cell carcinoma was rated under DC 7528-7500, and the 30 percent rating after treatment rested on the minimum for removal of a kidney.
Kidney function after surgery depends on how much kidney was removed. In one study of patients with small kidney tumors, the chance of staying free of a new GFR below 60 for three years was 80 percent after partial nephrectomy and 35 percent after radical nephrectomy. A GFR of 45 to 59 held for three consecutive months is 30 percent under renal dysfunction, so ask for repeat lab work rather than assuming the remaining kidney has fully compensated. If the voiding side of the picture is worse, say so and make sure the examiner evaluates both.
Is kidney cancer presumptive under the PACT Act?
Yes, for a covered veteran. Kidney cancer is a specified disease under 38 U.S.C. § 1120(b)(2)(G). Under § 1120(a), a specified disease becoming manifest in a covered veteran is considered incurred in or aggravated by service, notwithstanding the absence of any record of it during service, subject to the rebuttal provisions of § 1113.
Section 1120(c) takes the definition of "covered veteran" from 38 U.S.C. § 1119(c), which identifies the qualifying locations, airspace, and service periods: service on or after August 2, 1990 in Bahrain, Iraq, Kuwait, Oman, Qatar, Saudi Arabia, Somalia, or the United Arab Emirates, or on or after September 11, 2001 in Afghanistan, Djibouti, Egypt, Jordan, Lebanon, Syria, Yemen, Uzbekistan, or another country the Secretary determines relevant.
This is the citation that most published guidance gets wrong. Kidney cancer is not in 38 CFR § 3.320, which lists asthma, rhinitis, sinusitis, and nine rare cancers of the larynx, trachea, and lung. It is not in § 3.320a, which covers urinary bladder and ureter cancer. It is not in § 3.320b, which covers leukemias, multiple myelomas, myelodysplastic syndromes, and myelofibrosis. If a decision or a guide cites one of those sections for kidney cancer, the citation is wrong even when the outcome happens to be right.
The presumption addresses nexus only. It does not set a percentage and it does not remove the need for a pathology-confirmed diagnosis.
Is kidney cancer presumptive for radiation exposure?
This route is easy to miss because kidney cancer is not named on the list. Section 3.309(d)(2)(xv) lists "Cancer of the urinary tract," and the note to that section resolves it.
For the purposes of this section, the term "urinary tract" means the kidneys, renal pelves, ureters, urinary bladder, and urethra.
So kidney cancer is on the radiation-exposed veteran presumptive list. If you participated in a radiation-risk activity as defined at § 3.309(d)(3), the disease is presumed service connected subject to § 3.307, with no dose reconstruction and no nexus opinion required.
Radiation-risk activity is narrowly defined. It covers onsite participation in a test involving the atmospheric detonation of a nuclear device, the occupation of Hiroshima or Nagasaki by United States forces between August 6, 1945 and July 1, 1946, comparable prisoner-of-war internment in Japan during World War II, certain qualifying service at named gaseous diffusion plants, service on Amchitka Island, Alaska before January 1, 1974 involving exposure from the underground nuclear tests there, certain service that would qualify a Department of Energy employee for the Special Exposure Cohort, the Enewetak Atoll cleanup from 1977 through 1980, and the response efforts after the nuclear weapons accidents near Palomares, Spain (1966 to 1967) and Thule Air Force Base, Greenland (1968).
For ionizing radiation exposure that does not meet that definition, kidney cancer is separately listed as a radiogenic disease at 38 CFR § 3.311(b)(2)(xii). Under that section VA must obtain a dose estimate and refer the claim for a causation opinion. Skipping that development is a procedural error.
Camp Lejeune kidney cancer: the contaminated-water presumption
Yes, kidney cancer is presumptive for Camp Lejeune. It is listed in 38 CFR § 3.309(f) as a disease associated with contaminants in the Camp Lejeune water supply. Under 38 CFR § 3.307(a)(7), a veteran, former reservist, or former National Guard member with no less than 30 days of service at Camp Lejeune (consecutive or not) between August 1, 1953 and December 31, 1987 is presumed exposed, unless affirmative evidence shows otherwise. As with the other routes, the presumption addresses the connection to service; it does not set the percentage.
How to prove kidney cancer is service connected without a presumption
Where no presumption applies, 38 CFR § 3.303 governs. That route needs a pathology-confirmed diagnosis, a documented in-service disease, event, or exposure, and competent medical evidence linking them.
Document the exposure history concretely: duty location, dates, the substance involved, and the available service records. Camp Lejeune service is covered by the presumption above; for other installations with documented contaminated water supplies, check the current eligibility rules for the specific installation and period rather than assuming coverage.
Do not let a nexus opinion assert that an industrial chemical caused this veteran's cancer without addressing timing, dose, cell type, and competing risk factors. An opinion that skips those is easy for a reviewer to discount.
Why VA denies kidney cancer claims
Kidney cancer claims do better at the Board than the average claim. Across 1,036 decided Board rulings on kidney cancer from 2021 to 2026, 30.0% were granted, 20.8% denied and 49.2% remanded. A ruling is one issue the Board decided in one decision; one decision often rules on several issues. That grant rate is 5.3 points above the Board-wide 24.7 percent.
When the Board denied kidney cancer service connection, it found no link to service, and in many of those rulings it also found no qualifying in-service event or exposure. The patterns behind those findings, and behind low ratings after treatment, repeat.
The wrong authority. The claim cites 38 CFR § 3.320 for a cancer that section does not list, instead of the statute.
A missed presumption. The § 3.309(d) radiation route is overlooked because "kidney cancer" does not appear on the list by name, or VA skips the § 3.311 dose estimate when § 3.309(d) does not apply.
Service not documented. The records do not show the 30 days at Camp Lejeune, the covered PACT Act location, or the radiation-risk activity the presumption needs.
A direct opinion that skips the basics. The opinion names an exposure but never addresses timing, dose, cell type, or competing risk factors.
Treating the presumption as a rating. None of the presumptions sets the percentage.
Rating errors after treatment. The mandatory six-month examination is missed, a reduction does not follow § 3.105(e), a single GFR value is submitted instead of a three-month pattern, renal dysfunction is rated when voiding dysfunction is the predominant problem (or the reverse), or DC 7500 is overlooked after a whole kidney was removed.
When the Board sends a kidney cancer claim back instead of deciding it, the most common reason is an inadequate VA exam or opinion, followed by records VA still had to get and claims that never had a VA exam. The Board section below shows how often each denial and remand reason came up, results by what the appeal asked for, and how claims argued as direct and presumptive fared.
Questions veterans ask about kidney cancer
What is the VA rating for kidney cancer?
Kidney cancer is rated 100 percent under DC 7528 while it is active, during treatment, and for six months after treatment ends. VA then examines you and rates the residuals as renal or voiding dysfunction, whichever is predominant, unless the cancer has come back. If a whole kidney was removed, DC 7500 sets a minimum of 30 percent.
Is kidney cancer presumptive for Agent Orange?
No. Kidney cancer is not on the Agent Orange list in 38 CFR § 3.309(e), and 38 USC § 1116 names bladder cancer but not kidney cancer. A Vietnam-era veteran with kidney cancer can still qualify through Camp Lejeune service, the radiation list, or a direct claim with a medical opinion.
Is renal cell carcinoma covered by the PACT Act?
Yes, for a covered veteran. 38 USC § 1120 lists kidney cancer, and § 1119 defines covered veterans by service in listed countries on or after August 2, 1990 or September 11, 2001. The presumption comes from the statute, not from 38 CFR § 3.320.
Is kidney cancer presumptive for Camp Lejeune?
Yes. Kidney cancer is on the Camp Lejeune list in 38 CFR § 3.309(f). The presumption needs at least 30 days of service at Camp Lejeune, consecutive or not, between August 1, 1953 and December 31, 1987.
What is the VA rating after a nephrectomy?
When one kidney has been removed, DC 7500 gives a minimum rating of 30 percent, or a renal dysfunction rating if the other kidney is diseased. Without that, the rating depends on kidney function measured over three consecutive months and on any voiding problems.
Bottom Line
The rating side of kidney cancer is straightforward: 100 percent while active, a mandatory examination at six months, then voiding or renal dysfunction, whichever is predominant, with renal scored on GFR bands that require three months of persistence, and a 30 percent minimum under DC 7500 when a whole kidney is gone. The service-connection side is where claims are won and lost. Check all three presumptive routes before falling back on a direct nexus opinion, and cite the statute rather than the fine-particulate-matter regulation when you claim the PACT Act lane.
Related Conditions and Tools
Compare kidney disease, kidney stones, bladder cancer, and prostate cancer, which shares DC 7528. Review DC 7528 and organize pathology, imaging, and lab records with the Statement Builder and the Evidence Checklists.
Sources and limits
Legal sources: 38 CFR § 4.115a, § 4.115b, § 3.307, § 3.309, § 3.311, § 3.320, § 3.105, § 3.303, and 38 U.S.C. §§ 1119 and 1120, along with 38 CFR § 4.115, §§ 3.320a and 3.320b, and 38 U.S.C. § 1116, checked against the eCFR text in force on October 1, 2026. The DC 7528-7500 example is Board decision 23066365 (December 15, 2023). The nephrectomy figures are from Huang and colleagues, "Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study," Lancet Oncology (2006), read as a PubMed abstract. Board figures come from Claim Raven's read of 510,968 Board decisions from 2021 to 2026, which contain 1,376,193 rulings, including 1,143 rulings on kidney cancer; dismissed, withdrawn and moot rulings are excluded from the shares. These describe appealed claims, not your personal odds. Claim Raven is data analysis, not legal, medical, or VA-accredited advice.
